Novartis
NVS
#56
Rank
$210.24 B
Marketcap
$102.57
Share price
-0.12%
Change (1 day)
1.75%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

EPS for Novartis (NVS)

EPS in 2023 (TTM): $3.74

According to Novartis's latest financial reports the company's current EPS (TTM) is $3.74. In 2022 the company made an earnings per share (EPS) of $3.19 a decrease over its 2021 EPS that were of $10.72.

EPS history for Novartis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.7417.24%
2022$3.19-70.24%
2021$10.72201.97%
2020$3.55-30.53%
2019$5.11-5.89%
2018$5.4365.55%
2017$3.2816.31%
2016$2.82-61.84%
2015$7.3975.53%
2014$4.2112.27%
2013$3.75-2.6%
2012$3.852.12%
2011$3.77-11.92%
2010$4.2815.36%
2009$3.712.77%
2008$3.61-49.65%
2007$7.17132.04%
2006$3.0925.61%
2005$2.468.37%
2004$2.2714.07%
2003$1.998.32%
2002$1.8422.32%
2001$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$14.09 276.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.86-50.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97-20.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-14.97%๐Ÿ‡ซ๐Ÿ‡ท France
$1.82-51.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.97 6.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.98-46.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.50-6.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$2.00-153.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel